Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Unknown 1Terminated 1

Sponsor Class

NIH 2

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 1Breast 1

Conditions

Breast Neoplasms 18Rectal Neoplasms 10Colorectal Neoplasms 10Colonic Neoplasms 7Kidney Neoplasms 5Stomach Neoplasms 4Neuroblastoma 4Neoplasm Metastasis 4Liver Neoplasms 4Inflammatory Breast Neoplasms 4Carcinoma, Renal Cell 4Sarcoma 3Lung Neoplasms 3Gliosarcoma 3Glioblastoma 3Central Nervous System Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Carcinoma, Intraductal, Noninfiltrating 3Carcinoma, Hepatocellular 3Brain Neoplasms 3Urinary Bladder Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Pancreatic Neoplasms 2Liposarcoma 2Hemangiosarcoma 2Hemangiopericytoma, Malignant 2Head and Neck Neoplasms 2Glioma 2Fibrosarcoma 2Esophageal Neoplasms 2

Interventions

Doxorubicin 3Dexrazoxane 3Cyclophosphamide 3Razoxane 2Neoadjuvant Therapy 2Filgrastim 2oblimersen 1Trastuzumab 1Taxes 1Tamoxifen 1Radiotherapy 1Radiation 1Paclitaxel 1Methotrexate 1Leucovorin 1Granulocyte Colony-Stimulating Factor 1Fluorouracil 1Epirubicin 1Docetaxel 1Cisplatin 1Chemotherapy, Adjuvant 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NIH × Cardiotoxicity × Neoadjuvant Therapy × Clear all
NCT00019864 2015-06-08

Combination Chemotherapy Before and After Surgery in Treating Patients With Osteosarcoma

National Cancer Institute (NCI)

Phase 2 Terminated
100 enrolled
Sarcoma

Sarcoma, Osteosarcoma, Cardiotoxicity

NCT01093235 2010-03-25

Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Nonmetastatic Breast Cancer

National Cancer Institute (NCI)

Phase 3 Unknown
800 enrolled
Breast

Breast Neoplasms, Postoperative Complications, Breast Neoplasms, Male, Inflammatory Breast Neoplasms, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡